Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Non-Current Deffered Revenue: 2009-2012

Historic Non-Current Deffered Revenue for Avadel Pharmaceuticals (AVDL) over the last 4 years, with Dec 2012 value amounting to $181,000.

  • Avadel Pharmaceuticals' Non-Current Deffered Revenue was N/A to $136,000 in Q3 2013 from the same period last year, while for Sep 2013 it was $136,000, marking a year-over-year change of. This contributed to the annual value of $181,000 for FY2012, which is 88.18% down from last year.
  • Avadel Pharmaceuticals' Non-Current Deffered Revenue amounted to $181,000 in FY2012, which was down 88.18% from $1.5 million recorded in FY2011.
  • In the past 5 years, Avadel Pharmaceuticals' Non-Current Deffered Revenue registered a high of $6.0 million during FY2009, and its lowest value of $181,000 during FY2012.
  • Moreover, its 3-year median value for Non-Current Deffered Revenue was $1.5 million (2011), whereas its average is $1.7 million.
  • Data for Avadel Pharmaceuticals' Non-Current Deffered Revenue shows a maximum YoY crashed of 88.18% (in 2012) over the last 5 years.
  • Avadel Pharmaceuticals' Non-Current Deffered Revenue (Yearly) stood at $6.0 million in 2009, then crashed by 46.18% to $3.2 million in 2010, then crashed by 52.85% to $1.5 million in 2011, then plummeted by 88.18% to $181,000 in 2012.